Evaluation of  Serum Fibrinogen, Plasminogen, <i>α</i>2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM

<table>Expression of <i>α</i>2-anti-plasmin in the diabetic and control groups.</table>

Journal of Diabetes Research

fig2

Figure 2

Figure 2: Evaluation of  Serum Fibrinogen, Plasminogen, <i>α</i>2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM 

Figure 2 | Evaluation of  Serum Fibrinogen, Plasminogen, α2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM 